Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1857 USD | +1.20% | +2.31% | -14.11% |
Mar. 27 | Transcript : Matinas BioPharma Holdings, Inc., 2023 Earnings Call, Mar 27, 2024 | |
Mar. 27 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.11% | 46.58M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.12% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- MTNB Stock
- News Matinas BioPharma Holdings, Inc.
- Matinas BioPharma : Piper Sandler Cuts Matinas BioPharma Holdings to Neutral From Overweight, Price Target to $0.90 From $4